Afdhal NH - Search Results

1

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.

Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee WM, Reindollar R, King JW, Kwo PY, Ghalib RH, Freilich B, Nyberg LM, Zeuzem S, Poynard T, Vock DM, Pieper KS, Patel K, Tillmann HL, Noviello S, Koury K, Pedicone LD, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG. Thompson AJ, et al. Among authors: afdhal nh. Gastroenterology. 2010 Jul;139(1):120-9.e18. doi: 10.1053/j.gastro.2010.04.013. Epub 2010 Apr 24. Gastroenterology. 2010. PMID: 20399780

2

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group. Afdhal NH, et al. Gastroenterology. 2004 May;126(5):1302-11. doi: 10.1053/j.gastro.2004.01.027. Gastroenterology. 2004. PMID: 15131791 Clinical Trial.

3

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.

Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH; PROACTIVE Study Group. Pockros PJ, et al. Among authors: afdhal nh. Hepatology. 2004 Dec;40(6):1450-8. doi: 10.1002/hep.20482. Hepatology. 2004. PMID: 15565613 Clinical Trial.

4

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Sulkowski MS, et al. Among authors: afdhal nh. AIDS. 2005 Mar 24;19(6):585-92. doi: 10.1097/01.aids.0000163935.99401.25. AIDS. 2005. PMID: 15802977

5

Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.

Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, He Q, Koziel MJ, El Naggar KM, Rasenack J, Afdhal NH. Kamal SM, et al. Among authors: afdhal nh. Gastroenterology. 2006 Mar;130(3):632-8. doi: 10.1053/j.gastro.2006.01.034. Gastroenterology. 2006. PMID: 16530503 Clinical Trial.

6

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD; Virahep-C Study Group. Conjeevaram HS, et al. Gastroenterology. 2006 Aug;131(2):470-7. doi: 10.1053/j.gastro.2006.06.008. Gastroenterology. 2006. PMID: 16890601 Clinical Trial.

7

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.

McHutchison J, Poynard T, Afdhal N; International Fibrosis Group Meeting Participants. McHutchison J, et al. Clin Gastroenterol Hepatol. 2006 Oct;4(10):1214-1220. doi: 10.1016/j.cgh.2006.07.006. Epub 2006 Sep 18. Clin Gastroenterol Hepatol. 2006. PMID: 16979947 Review.

8

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

Pockros PJ, Schiff ER, Shiffman ML, McHutchison JG, Gish RG, Afdhal NH, Makhviladze M, Huyghe M, Hecht D, Oltersdorf T, Shapiro DA. Pockros PJ, et al. Among authors: afdhal nh. Hepatology. 2007 Aug;46(2):324-9. doi: 10.1002/hep.21664. Hepatology. 2007. PMID: 17654603 Clinical Trial.

9

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial.

Jacobson IM, Brown RS Jr, Freilich B, Afdhal N, Kwo PY, Santoro J, Becker S, Wakil AE, Pound D, Godofsky E, Strauss R, Bernstein D, Flamm S, Pauly MP, Mukhopadhyay P, Griffel LH, Brass CA; WIN-R Study Group. Jacobson IM, et al. Hepatology. 2007 Oct;46(4):971-81. doi: 10.1002/hep.21932. Hepatology. 2007. PMID: 17894303 Clinical Trial.

10

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.

McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, Afdhal NH, Jacobson IM, Muir A, Al-Adhami M, Morris ML, Lekstrom-Himes JA, Efler SM, Davis HL. McHutchison JG, et al. Among authors: afdhal nh. Hepatology. 2007 Nov;46(5):1341-9. doi: 10.1002/hep.21773. Hepatology. 2007. PMID: 17929306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page